252 related articles for article (PubMed ID: 33414463)
1. KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.
Cao Z; Shi X; Tian F; Fang Y; Wu JB; Mrdenovic S; Nian X; Ji J; Xu H; Kong C; Xu Y; Chen X; Huang Y; Wei X; Yu Y; Yang B; Chung LWK; Wang F
Cell Death Dis; 2021 Jan; 12(1):2. PubMed ID: 33414463
[TBL] [Abstract][Full Text] [Related]
2. Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression.
Yıldırım-Buharalıoğlu G
Mol Pharmacol; 2022 Feb; 101(2):106-119. PubMed ID: 34862309
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
[TBL] [Abstract][Full Text] [Related]
4. KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPβ transcription.
Qin M; Han F; Wu J; Gao FX; Li Y; Yan DX; He XM; Long Y; Tang XP; Ren DL; Gao Y; Dai TY
BMC Cancer; 2021 May; 21(1):559. PubMed ID: 34001062
[TBL] [Abstract][Full Text] [Related]
5. Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer.
Wu MJ; Chen CJ; Lin TY; Liu YY; Tseng LL; Cheng ML; Chuu CP; Tsai HK; Kuo WL; Kung HJ; Wang WC
Theranostics; 2021; 11(16):7779-7796. PubMed ID: 34335964
[No Abstract] [Full Text] [Related]
6. Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs.
Mathur R; Sehgal L; Havranek O; Köhrer S; Khashab T; Jain N; Burger JA; Neelapu SS; Davis RE; Samaniego F
Haematologica; 2017 Feb; 102(2):373-380. PubMed ID: 27742770
[TBL] [Abstract][Full Text] [Related]
7. The Epigenetic Regulation of OLIG2 by Histone Demethylase KDM6B in Glioma Cells.
Sui A; Han B; Ren W; He W; Gao C; Han X; Liu S; Zhang Y; Qi X; Guo X
J Mol Neurosci; 2022 May; 72(5):939-946. PubMed ID: 35132566
[TBL] [Abstract][Full Text] [Related]
8. Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenografts.
Sanchez A; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
Cancer Genomics Proteomics; 2022; 19(3):339-349. PubMed ID: 35430567
[TBL] [Abstract][Full Text] [Related]
9. KDM6B promotes ovarian cancer cell migration and invasion by induced transforming growth factor-β1 expression.
Liang S; Yao Q; Wei D; Liu M; Geng F; Wang Q; Wang YS
J Cell Biochem; 2019 Jan; 120(1):493-506. PubMed ID: 30277596
[TBL] [Abstract][Full Text] [Related]
10. MiR-10a functions as a tumor suppressor in prostate cancer via targeting KDM4A.
Mu H; Xiang L; Li S; Rao D; Wang S; Yu K
J Cell Biochem; 2019 Apr; 120(4):4987-4997. PubMed ID: 30302800
[TBL] [Abstract][Full Text] [Related]
11. KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma.
D'Oto A; Fang J; Jin H; Xu B; Singh S; Mullasseril A; Jones V; Abu-Zaid A; von Buttlar X; Cooke B; Hu D; Shohet J; Murphy AJ; Davidoff AM; Yang J
Nat Commun; 2021 Dec; 12(1):7204. PubMed ID: 34893606
[TBL] [Abstract][Full Text] [Related]
12. Histone demethylase KDM6B regulates 1,25-dihydroxyvitamin D3-induced senescence in glioma cells.
Sui A; Xu Y; Pan B; Guo T; Wu J; Shen Y; Yang J; Guo X
J Cell Physiol; 2019 Aug; 234(10):17990-17998. PubMed ID: 30825201
[TBL] [Abstract][Full Text] [Related]
13. c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer.
Maina PK; Shao P; Liu Q; Fazli L; Tyler S; Nasir M; Dong X; Qi HH
Oncotarget; 2016 Nov; 7(46):75585-75602. PubMed ID: 27689328
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targeting of histone lysine demethylase KDM4B blocks the growth of castration-resistant prostate cancer.
Duan L; Chen YA; Liang Y; Chen Z; Lu J; Fang Y; Cao J; Lu J; Zhao H; Pong RC; Hernandez E; Kapur P; Tran TAT; Smith T; Martinez ED; Ahn JM; Hsieh JT; Luo JH; Liu ZP
Biomed Pharmacother; 2023 Feb; 158():114077. PubMed ID: 36495660
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
[TBL] [Abstract][Full Text] [Related]
16. KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma.
Jiang Y; Li F; Gao B; Ma M; Chen M; Wu Y; Zhang W; Sun Y; Liu S; Shen H
Theranostics; 2021; 11(8):3868-3881. PubMed ID: 33664867
[No Abstract] [Full Text] [Related]
17. Regulation of histone demethylase KDM6B by hypoxia-inducible factor-2α.
Guo X; Tian Z; Wang X; Pan S; Huang W; Shen Y; Gui Y; Duan X; Cai Z
Acta Biochim Biophys Sin (Shanghai); 2015 Feb; 47(2):106-13. PubMed ID: 25520177
[TBL] [Abstract][Full Text] [Related]
18. Histone Demethylase JARID1B Is Overexpressed in Osteosarcoma and Upregulates Cyclin D1 Expression via Demethylation of H3K27me3.
Wang W; Zheng K; Pei Y; Zhang X
Oncol Res; 2018 Apr; 26(3):373-384. PubMed ID: 28492139
[TBL] [Abstract][Full Text] [Related]
19. Critical role of histone demethylase Jumonji domain-containing protein 3 in the regulation of neointima formation following vascular injury.
Luo X; Yang D; Wu W; Long F; Xiao C; Qin M; Law BY; Suguro R; Xu X; Qu L; Liu X; Zhu YZ
Cardiovasc Res; 2018 Dec; 114(14):1894-1906. PubMed ID: 29982434
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling.
Macedo-Silva C; Miranda-Gonçalves V; Tavares NT; Barros-Silva D; Lencart J; Lobo J; Oliveira Â; Correia MP; Altucci L; Jerónimo C
Signal Transduct Target Ther; 2023 Oct; 8(1):395. PubMed ID: 37840069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
